Sign In
Buy ESPR
$3.14
+0 (+0%)
At Close: Jun 03, 2026
Should You Buy These 4 Biotech Stocks With Recent Drug Approvals?
10:45am, Wednesday, 15'th Apr 2020
These companies scored recent drug approvals. It's worth looking into their stocks to see if they're a buy now.
Geode Capital Management LLC Sells 7,099 Shares of Esperion Therapeutics Inc (NASDAQ:ESPR)
10:20am, Wednesday, 15'th Apr 2020
Geode Capital Management LLC trimmed its holdings in shares of Esperion Therapeutics Inc (NASDAQ:ESPR) by 2.0% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 3
Stocks To Watch: Big Banks And Vaccine Players In The Spotlight
12:35pm, Saturday, 11'th Apr 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More
01:12pm, Friday, 10'th Apr 2020
The COVID-19 pandemic has stopped enrollment in many clinical trials and postponed the start of others but there is still life in the life sciences
3,926 Shares in Esperion Therapeutics Inc (NASDAQ:ESPR) Acquired by Janus Henderson Group PLC
10:34am, Friday, 10'th Apr 2020
Janus Henderson Group PLC acquired a new stake in Esperion Therapeutics Inc (NASDAQ:ESPR) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Com
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
01:47pm, Thursday, 09'th Apr 2020
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Tilray (TLRY) in Focus: Stock Moves 9.6% Higher
01:47pm, Thursday, 09'th Apr 2020
Tilray (TLRY) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.
Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare Conference
12:00pm, Thursday, 09'th Apr 2020
Esperion (ESPR) today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat at the 19th Annual Needham Virtual Healthcare Conference o
Northland Securities Thinks PolarityTE's Stock is Going to Recover
12:59pm, Wednesday, 08'th Apr 2020
Northland Securities analyst Carl Byrnes maintained a Buy rating on PolarityTE (PTE) today and set a price target of $8.00. The company's shares closed
Northland Securities Thinks PolarityTE’s Stock is Going to Recover
12:59pm, Wednesday, 08'th Apr 2020
Northland Securities analyst
Carl Byrnes
maintained a
Buy
rating on PolarityTE (
PTE
–
Research Report
) today and set a price target of
$8.00
. The company’s shares closed last Tuesday at $0.87,
Analysts Offer Insights on Healthcare Companies: Cutera (CUTR) and GW Pharma (GWPH)
11:33am, Wednesday, 08'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cutera (CUTR) and GW Pharma (GWPH). Cutera (CUTR) In a report released
Analysts Offer Insights on Healthcare Companies: Cutera (NASDAQ: CUTR) and GW Pharma (NASDAQ: GWPH)
11:33am, Wednesday, 08'th Apr 2020
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Cutera (CUTR – Research Report)
Esperion Therapeutics (NASDAQ:ESPR) Stock Rating Reaffirmed by Needham & Company LLC
09:36am, Wednesday, 08'th Apr 2020
Esperion Therapeutics (NASDAQ:ESPR)‘s stock had its “buy” rating reiterated by research analysts at Needham & Company LLC in a research report issued on Monday, AnalystRatings.com reports. They
Esperion's Cholesterol Drugs Receive Approval in Europe
02:43pm, Tuesday, 07'th Apr 2020
Esperion (ESPR) announces approval for cholesterol drugs Nilemdo and Nustendi in Europe.
